Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 8/20 | 0.59 |
| ▸ | FNTB | P49356 | 8/20 | 0.59 |
| ▸ | BAZ2B | Q9UIF8 | 10/20 | 0.59 |
| ▸ | BAZ2A | Q9UIF9 | 10/20 | 0.59 |
| ▸ | BRD4 | O60885 | 2/20 | 0.49 |
| ▸ | BRD9 | Q9H8M2 | 2/20 | 0.49 |
| ▸ | BRD2 | P25440 | 1/20 | 0.49 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26301013 | 0.89 | FNTA (0.49) | FNTAFNTBBAZ2BBAZ2ABRD4 | |
| SCHEMBL26301880 | 0.89 | FNTA (0.67) | FNTAFNTBBAZ2BBAZ2AMAPT | |
| SCHEMBL26302091 | 0.88 | BAZ2B (0.74) | FNTAFNTBBAZ2BBAZ2ABRD4 | |
| SCHEMBL26301414 | 0.88 | FNTA (0.69) | FNTAFNTBBAZ2BBAZ2ABRD4 | |
| SCHEMBL26301313 | 0.87 | BAZ2B (0.52) | FNTAFNTBBAZ2BBAZ2ABRD4 | |
| SCHEMBL26301618 | 0.85 | BAZ2B (0.58) | FNTAFNTBBAZ2BBAZ2ABRD4 | |
| SCHEMBL26301845 | 0.84 | FNTA (0.61) | FNTAFNTBBAZ2BBAZ2ABRD4 | |
| SCHEMBL26301430 | 0.84 | FNTA (0.57) | FNTAFNTBBAZ2BBAZ2AMAPT | |
| SCHEMBL26301438 | 0.84 | BAZ2B (0.74) | FNTAFNTBBAZ2BBAZ2ABRD4 | |
| SCHEMBL26301036 | 0.83 | FNTA (0.51) | FNTAFNTBBAZ2BBAZ2ABRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4233864-A1 | INTERFERON GENE STIMULATOR COMPOSITION COMPRISING INDOLIZINE DERIVATIVE AS ACTIVE INGREDIENT | Ajou University Industry-Academic Cooperation Foundation (KR) | 2023-08-30 | — | — | EP | disclosed |